CASQ2 and catecholaminergic polymorphic ventricular tachycardia: The first indications of such phenomena have been obtained using CASQ2 KO CPVT mouse model where Knollmann et al. [43] documented dramatic increase in SR volume, potentially a compensatory change to preserve SR Ca2+ buffering capacity in the absence of CASQ2, a major luminal Ca2+ buffer.